Ki67 in Breast Cancer Assay: An Ad Hoc Testing Recommendation from the Canadian Association of Pathologists Task Force

Ki67, a marker of cellular proliferation, is commonly assessed in surgical pathology laboratories. In breast cancer, Ki67 is an established prognostic factor with higher levels associated with worse long-term survival. However, Ki67 IHC is considered of limited clinical use in breast cancer manageme...

Descripción completa

Detalles Bibliográficos
Autores principales: Faragalla, Hala, Plotkin, Anna, Barnes, Penny, Lu, Fang-I, Kos, Zuzana, Mulligan, Anna Marie, Bane, Anita, Nofech Mozes, Sharon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047249/
https://www.ncbi.nlm.nih.gov/pubmed/36975446
http://dx.doi.org/10.3390/curroncol30030233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047249/
https://www.ncbi.nlm.nih.gov/pubmed/36975446
http://dx.doi.org/10.3390/curroncol30030233

Ejemplares similares